Key result
Age ≥75 linked to ~2-fold higher rate of AV conduction abnormalities during syncope EPS.
Why the study?
Syncope in elderly patients with heart disease is a growing problem with often difficult aetiological diagnosis, motivating evaluation of the value of electrophysiological study in this population.
What is the diagnostic utility and prognostic value of electrophysiological study in elderly patients (≥75 years) with syncope and heart disease compared to younger patients?
Observational (n=182)
What is the diagnostic utility and prognostic value of electrophysiological study in elderly patients (≥75 years) with syncope and heart disease compared to younger patients?
Electrophysiological study is highly useful in elderly patients with syncope and heart disease, frequently identifying treatable AV conduction abnormalities, though overall prognosis remains driven by age and LVEF.
Answers are grounded in this paper and cite their sources.
EPS may identify more treatable AV issues in elderly syncope patients; leaves open prognostic value beyond age and LVEF.
BACKGROUND: Syncope in elderly patients with heart disease is a growing problem. Its aetiological diagnosis is often difficult. We intended to investigate the value of the electrophysiological study (EPS) in old patients with syncope and heart disease. METHODS: EPS was performed in 182 consecutive patients with syncope and heart disease, among whom 62 patients were ≥75 years old and 120 patients <75. RESULTS: Left ventricular ejection fraction was 43.9±11.7% in patients ≥75 and 41.1±12.6% in patients <75. During EPS, induced sustained ventricular arrhythmias were as frequent in both groups (27.4% in patients ≥75 versus 27.5% in patients <75, p=0.99) whereas AV conduction abnormalities were more frequent in older patients (37.1% in patients ≥75 versus 18.3% in patients <75, p<0.005). Syncope remained unexplained in 35.5% of patients ≥75 and in 51.7% of patients <75 (p>0.04). ICD was more likely to be implanted in younger patients than in patients ≥75 years (37.5% vs 21% respectively, p<0.009). During a mean follow-up period of 3.3±3 years, the 4-year-survival rate was 66.9±6.8 % in patients ≥75 and 75.9±6.2 % in patients <75 years. The main cause of death was heart failure in both groups. The factors related to a worse outcome in a multivariate analysis were low LVEF and higher age. CONCLUSION: Complete EPS allows the identification of treatable causes in a high proportion of elderly patients with syncope and heart disease. Yet, the prognosis of these patients is mainly related to LVEF and age.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2015) conducted an observational in Syncope and heart disease (n=182). Age ≥75 years vs. Age <75 years was evaluated on AV conduction abnormalities during EPS (p=<0.005). During electrophysiological study for syncope and heart disease, AV conduction abnormalities were more frequent in patients ≥75 years compared to younger patients.
Synapse has enriched 10 related papers. Consider them for comparative context: